Modulation of the Gut Microbiota during High-Dose Glycerol Monolaurate-Mediated Amelioration of Obesity in Mice Fed a High-Fat Diet

• Published in: mBio 2020-04, Vol.11 (2)
• Main Authors: Zhao, Minjie, Jiang, Zengliang, Cai, Haiying, Li, Yang, Mo, Qiufen, Deng, Lingli, Zhong, Hao, Liu, Tao, Zhang, Hui, Kang, Jing X, Feng, Fengqin
• Format: Article
• Language: English
• Subjects: Animals; Bifidobacterium - metabolism; Body Weight; Diet, High-Fat; Dysbiosis; Gastrointestinal Microbiome - drug effects; glycerol monolaurate; gut microbiota; hepatic transcriptome; Host-Microbe Biology; Hyperlipidemias - prevention & control; Inflammation - prevention & control; Laurates - administration & dosage; Lipid Metabolism - drug effects; Liver - drug effects; Male; Metabolome; Mice; Mice, Inbred C57BL; Monoglycerides - administration & dosage; obesity; Obesity - microbiology; Obesity - prevention & control; serum metabolome; Transcriptome
• ISSN: 2161-2129; 2150-7511
• DOI: 10.1128/mbio.00190-20

Obesity and associated metabolic disorders are worldwide public health issues. The gut microbiota plays a key role in the pathophysiology of diet-induced obesity. Glycerol monolaurate (GML) is a widely consumed food emulsifier with antibacterial properties. Here, we explore the anti-obesity effect of GML (1,600 mg/kg of body weight) in high-fat diet (HFD)-fed mice. HFD-fed mice were treated with 1,600 mg/kg GML. Integrated microbiome, metabolome, and transcriptome analyses were used to systematically investigate the metabolic effects of GML, and antibiotic treatment was used to assess the effects of GML on the gut microbiota. Our data indicated that GML significantly reduced body weight and visceral fat deposition, improved hyperlipidemia and hepatic lipid metabolism, and ameliorated glucose homeostasis and inflammation in HFD-fed mice. Importantly, GML modulated HFD-induced gut microbiota dysbiosis and selectively increased the abundance of Antibiotic treatment abolished all the GML-mediated metabolic improvements. A multiomics (microbiome, metabolome, and transcriptome) association study showed that GML significantly modulated glycerophospholipid metabolism, and the abundance of strongly correlated with the metabolites and genes that participated in glycerophospholipid metabolism. Our results indicated that GML may be provided for obesity prevention by targeting the gut microbiota and regulating glycerophospholipid metabolism.